Monogram Technologies Inc. Company Analysis & Research
Monogram Technologies develops surgical robots to enable placement of patient-optimized orthopedic implants, and was acquired by Zimmer Biomet Holdings as of October 7, 2025. The company revolutionizes orthopedic joint replacement surgery with its mBôs robotic technology that links 3D printing and robotics with advanced pre-operative imaging.
The company's vision is to combine a surgical robot that addresses economic and clinical pain points with personalized implants, moving away from the generic "one size fits none" model that is too costly. A historic milestone was achieved with the world's first fully autonomous saw-based robotic knee replacement surgery on a live patient on July 26, 2025, at Krishna Shalby Hospital in Ahmedabad, India.
Company Overview
Founded: 2015. Headquarters: Austin, Texas. Market Cap: $177M (acquisition value). Ticker: MGRM (NASDAQ).
Industry
Medical Devices - Surgical Robotics & Orthopedic Implants
Cyborg Score: 8/10 — Strong
Innovative surgical robotics platform with FDA clearance and proven autonomous capabilities positioned for rapid adoption through Zimmer Biomet integration.
The company received FDA 510(k) clearance for its mBôs TKA System for total knee arthroplasty. Zimmer Biomet's acquisition at $4.04 per share represents approximately $177 million equity value. Strong technology validation with first autonomous robotic knee surgery completed and clinical trials underway.
Key Strategic Insights for Monogram Technologies Inc.
- World's first fully autonomous saw-based robotic knee replacement completed July 26, 2025, validating autonomous surgical technology
- FDA 510(k) clearance for mBôs TKA System designed for enhanced safety, efficiency, and accuracy in knee replacement
- Acquired by Zimmer Biomet at $4.04/share for ~$177M, providing distribution and market access through major medtech leader
- 102-patient multi-center clinical trial in India underway evaluating system safety and effectiveness with Consensus CKS implants
Recent Developments
- (July 2025) Completed world's first autonomous saw-based robotic knee replacement surgery on live patient
- (May 2025) Received FDA 510(k) clearance for mBôs TKA System for total knee arthroplasty
- (October 2025) Acquisition by Zimmer Biomet completed at $4.04 per share
Competitors & Competitive Landscape
- Stryker Corporation — Robotic-assisted knee and hip replacement system
- Zimmer Biomet — Robotic-assisted knee arthroplasty platform
- Smith+Nephew — AI-enabled robotic-assisted knee replacement
The company takes a similar approach to Mako in robotic orthopedic surgery. Main competitors include Stryker (Mako Surgical Systems), Johnson & Johnson (Orthotaxy), and Smith+Nephew in robotic-assisted joint replacement. Monogram differentiates through autonomous surgical capabilities, 3D-printed custom implants, and reduced operative time targeting.
More Company Research
Princeton Bancorp, Inc. Marie Brizard Wine & Spirits Global Dominion Access, S.A. SBS Holdings, Inc. Labrador Iron Ore Royalty Corporation Believe S.A. Kadokawa Corporation The New York Times Company Wyndham Hotels & Resorts, Inc. Trelleborg AB Kao Corporation Take-Two Interactive Software, Inc. Watania International Holding PJSC People Can Fly Nankai Tatsumura Construction Co., Ltd.Full Company Research Reports
Looking for a more in-depth analysis of Monogram Technologies Inc.? AskCyborg's Company Research section contains full AI-generated reports with detailed financials, strategic analysis, and Cyborg Score ratings. Browse the complete company research library or explore industry research reports.
AskCyborg provides AI-powered company research and analysis. Visit AskCyborg for full reports, Cyborg Score ratings, and analyst podcasts.